Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival

10.1056/NEJMoa043330

10.1007/s00415-009-5167-6

Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 1990; 50:8017-22; PMID:2253244

10.1016/1040-8428(94)00144-I

10.3109/07357907.2010.483506

10.1007/s00280-009-1041-6

10.2174/156800912799277557

10.1073/pnas.91.16.7727

10.1073/pnas.95.10.5724

10.1200/JCO.2010.28.6963

10.1158/1078-0432.CCR-13-0709

10.1097/CJI.0000000000000082

10.1089/15258160152509145

10.1080/14653240802301872

10.1016/j.jcyt.2013.06.017

10.1038/mt.2014.219

Jannot CB, Beerli RR, Mason S, Gullick WJ, Hynes NE. Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. Oncogene 1996; 13:275-82; PMID:8710366

Beers R, Chowdhury P, Bigner D, Pastan I. Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display. Clin Cancer Res 2000; 6:2835-43; PMID:10914732

10.1002/ijc.2910600120

10.1016/j.ccr.2006.03.030

10.1158/0008-5472.CAN-03-3775

10.1093/neuonc/not093

10.1016/j.ccr.2005.03.003

10.1038/onc.2010.195

10.1007/s11060-010-0251-4

10.1002/1097-0142(19950901)76:5%3c840::AID-CNCR2820760519%3e3.0.CO;2-R

10.1097/00002371-200409000-00009

10.1038/nrc3918

10.1056/NEJMoa1407222

10.1038/srep11483

Frederick L, Wang XY, Eley G, James CD. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res 2000; 60:1383-7; PMID:10728703

10.1016/j.ccr.2013.09.004

10.1038/mt.2013.185

10.1038/mtna.2013.32

10.1038/sj.onc.1202489

10.1126/scitranslmed.aaa4963

10.4161/onci.28147

Maurer-Gebhard M, Schmidt M, Azemar M, Altenschmidt U, Stöcklin E, Wels W, Groner B. Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells. Cancer Res 1998; 58:2661-6; PMID:9635594

10.1002/ijc.28585

10.1007/s00262-012-1212-x

10.1089/10430340252898984

10.1002/ijc.2910630414

10.1371/journal.pone.0061267